Friday, 18 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Policy / Regulatory
NMPA Updates 2025 Edition of Medical Narcotic and Psychotropic Substances Catalogs
July 28, 2025
Company
Deals
Tibet Aim Pharm’s Major Shareholder Transfers Stake to Beijing Fuhao
July 28, 2025
Company
Drug
Roche’s Elevidys Receives Negative CHMP Opinion for Duchenne Muscular Dystrophy
July 28, 2025
Company
Drug
Aidea Pharma’s Aitribond Approved by Zanzibar Food and Drug Agency
July 28, 2025
Company
Deals
Mirxes and NAGAWA Launch Free Gastric Cancer Screening Project in Japan
July 28, 2025
Company
Drug
Ascletis Pharma Doses First Patients in U.S. Phase 2a Trial for Monthly GLP-1 Agonist ASC30
July 28, 2025
Company
Drug
Sobi North America’s Doptelet Approved by FDA for Pediatric ITP Treatment
July 28, 2025
Company
Deals
Hengrui and GSK Enter Global Licensing Pact for PDE3/4 Inhibitor HRS-9821
July 28, 2025
Company
Drug
Pfizer and BioNTech’s LP.8.1 COVID-19 Vaccine Gets EMA CHMP Nod
July 28, 2025
Company
Medical Device
Sansure Biotech’s Gene Polymorphism Detection Kits Receive NMPA Class III IVD Certification
July 28, 2025
Policy / Regulatory
NMPA Approves Ambroxol Hydrochloride Oral Drops for Over-the-Counter Sale
July 28, 2025
Company
Drug
Biogen’s Zurzuvae Receives Positive CHMP Opinion for Postpartum Depression Treatment
July 28, 2025
1
2
…
297
298
299
300
301
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?